Charles Atkinson

Array ( [id] => 6874483 [patent_doc_number] => 20030194780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-16 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/164829 [patent_app_country] => US [patent_app_date] => 2001-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 238 [patent_figures_cnt] => 238 [patent_no_of_words] => 188343 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20030194780.pdf [firstpage_image] =>[orig_patent_app_number] => 10164829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6787200 [patent_doc_number] => 20030138439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/143031 [patent_app_country] => US [patent_app_date] => 2001-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 237 [patent_figures_cnt] => 237 [patent_no_of_words] => 188414 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20030138439.pdf [firstpage_image] =>[orig_patent_app_number] => 10143031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1002529 [patent_doc_number] => 06908984 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-21 [patent_title] => 'Megakaryocytic protein tyrosine kinase I' [patent_app_type] => utility [patent_app_number] => 09/977261 [patent_app_country] => US [patent_app_date] => 2001-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 28 [patent_no_of_words] => 12785 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/908/06908984.pdf [firstpage_image] =>[orig_patent_app_number] => 09977261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 732201 [patent_doc_number] => 07037677 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-02 [patent_title] => 'Megakaryocytic protein tyrosine kinase I' [patent_app_type] => utility [patent_app_number] => 09/977260 [patent_app_country] => US [patent_app_date] => 2001-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 28 [patent_no_of_words] => 11281 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/037/07037677.pdf [firstpage_image] =>[orig_patent_app_number] => 09977260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 663636 [patent_doc_number] => 07101974 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-05 [patent_title] => 'TNF-αvariants' [patent_app_type] => utility [patent_app_number] => 09/981289 [patent_app_country] => US [patent_app_date] => 2001-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 25 [patent_no_of_words] => 27764 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/101/07101974.pdf [firstpage_image] =>[orig_patent_app_number] => 09981289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6560358 [patent_doc_number] => 20020164693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'TM4SF receptor polynucleotides, polypeptides, and antibodies' [patent_app_type] => new [patent_app_number] => 09/972970 [patent_app_country] => US [patent_app_date] => 2001-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 105646 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20020164693.pdf [firstpage_image] =>[orig_patent_app_number] => 09972970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 680621 [patent_doc_number] => 07084257 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-01 [patent_title] => 'Fully human antibody Fab fragments with human interferon-gamma neutralizing activity' [patent_app_type] => utility [patent_app_number] => 09/972656 [patent_app_country] => US [patent_app_date] => 2001-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 26716 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/084/07084257.pdf [firstpage_image] =>[orig_patent_app_number] => 09972656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1088851 [patent_doc_number] => 06828101 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-12-07 [patent_title] => 'Methods of screening for modifiers of potassium channel protein activity' [patent_app_type] => B2 [patent_app_number] => 09/965830 [patent_app_country] => US [patent_app_date] => 2001-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 17 [patent_no_of_words] => 17313 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/828/06828101.pdf [firstpage_image] =>[orig_patent_app_number] => 09965830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 708133 [patent_doc_number] => 07060800 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-13 [patent_title] => 'Antibodies binding the TNF related protein, TNF-X' [patent_app_type] => utility [patent_app_number] => 09/949192 [patent_app_country] => US [patent_app_date] => 2001-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 24802 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/060/07060800.pdf [firstpage_image] =>[orig_patent_app_number] => 09949192 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6638926 [patent_doc_number] => 20020086975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'P2u2 receptor antibodies' [patent_app_type] => new [patent_app_number] => 09/947922 [patent_app_country] => US [patent_app_date] => 2001-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10694 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20020086975.pdf [firstpage_image] =>[orig_patent_app_number] => 09947922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1115230 [patent_doc_number] => 06800447 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-10-05 [patent_title] => 'Methods for identifying compounds which bind the active CCR5 chemokine receptor' [patent_app_type] => B2 [patent_app_number] => 09/939226 [patent_app_country] => US [patent_app_date] => 2001-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 34 [patent_no_of_words] => 14769 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/800/06800447.pdf [firstpage_image] =>[orig_patent_app_number] => 09939226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 979170 [patent_doc_number] => 06930174 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-16 [patent_title] => 'CCR5 chemokine receptor-specific antibodies' [patent_app_type] => utility [patent_app_number] => 09/938703 [patent_app_country] => US [patent_app_date] => 2001-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 34 [patent_no_of_words] => 11220 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/930/06930174.pdf [firstpage_image] =>[orig_patent_app_number] => 09938703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6276388 [patent_doc_number] => 20020106742 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Nucleic acids encoding active and inactive CCR5 chemokine receptors' [patent_app_type] => new [patent_app_number] => 09/938719 [patent_app_country] => US [patent_app_date] => 2001-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 10994 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20020106742.pdf [firstpage_image] =>[orig_patent_app_number] => 09938719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6715803 [patent_doc_number] => 20030027151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Regulator gene and system useful for the diagnosis and therapy of osteoporosis' [patent_app_type] => new [patent_app_number] => 09/931375 [patent_app_country] => US [patent_app_date] => 2001-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 27761 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027151.pdf [firstpage_image] =>[orig_patent_app_number] => 09931375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5860112 [patent_doc_number] => 20020123618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-05 [patent_title] => 'Leucine-rich repeat-containing G-protein coupled receptor-8 molecules and uses thereof' [patent_app_type] => new [patent_app_number] => 09/928175 [patent_app_country] => US [patent_app_date] => 2001-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 40274 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20020123618.pdf [firstpage_image] =>[orig_patent_app_number] => 09928175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6536890 [patent_doc_number] => 20020137137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Interferon-like molecules and uses thereof' [patent_app_type] => new [patent_app_number] => 09/927850 [patent_app_country] => US [patent_app_date] => 2001-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 36641 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137137.pdf [firstpage_image] =>[orig_patent_app_number] => 09927850 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1316295 [patent_doc_number] => 06605272 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-08-12 [patent_title] => 'Methods of using zalpha11 ligand' [patent_app_type] => B2 [patent_app_number] => 09/923246 [patent_app_country] => US [patent_app_date] => 2001-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 75556 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/605/06605272.pdf [firstpage_image] =>[orig_patent_app_number] => 09923246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 448084 [patent_doc_number] => 07250165 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-31 [patent_title] => 'Anti-TNF antibodies, compositions, methods and uses' [patent_app_type] => utility [patent_app_number] => 09/920137 [patent_app_country] => US [patent_app_date] => 2001-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 27 [patent_no_of_words] => 42260 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/250/07250165.pdf [firstpage_image] =>[orig_patent_app_number] => 09920137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6590078 [patent_doc_number] => 20020041870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-11 [patent_title] => 'Novel genes expressed in obese rat hypothalamus' [patent_app_type] => new [patent_app_number] => 09/912447 [patent_app_country] => US [patent_app_date] => 2001-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28272 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20020041870.pdf [firstpage_image] =>[orig_patent_app_number] => 09912447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7645458 [patent_doc_number] => 06472512 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-29 [patent_title] => 'Keratinocyte derived interferon' [patent_app_type] => B1 [patent_app_number] => 09/908594 [patent_app_country] => US [patent_app_date] => 2001-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 138218 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/472/06472512.pdf [firstpage_image] =>[orig_patent_app_number] => 09908594 [rel_patent_id] =>[rel_patent_doc_number] =>)